RCT
Bone Density Trial Tests Combination Therapy
This randomized trial found that menopausal hormone therapy and Gushukang were associated with improved bone mineral density over six months, with the combination showing the strongest improvement. The result highlights the importance of early bone-protection planning after menopause, while any therapy should be selected with clinical guidance.
Citation
Liu L, Ruan X, Gu M, Li Y, Yang Y, Cheng J, Jiang L, Wang Z, Zhang M, Liu A, Mueck AO. A randomized controlled trial on the effect of Gushukang on bone mineral density in perimenopausal and postmenopausal women. Gynecol Endocrinol. 2026;42(1):2659980. doi:10.1080/09513590.2026.2659980.
View Source